{
    "eid": "2-s2.0-85104356251",
    "title": "In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life",
    "cover-date": "2022-08-12",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "antioxidants",
        "deficit schizophrenia",
        "neuro-immune",
        "oxidative stress",
        "psychiatry",
        "tryptophan catabolites"
    ],
    "authors": [
        "Michael Maes",
        "Buranee Kanchanatawan"
    ],
    "citedby-count": 10,
    "ref-count": 60,
    "ref-list": [
        "How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse outcome pathways with the phenome of schizophrenia",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "Schizophrenia phenomenology revisited: Positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia",
        "Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention, and social cognition",
        "The effects of tryptophan catabolites on negative symptoms and deficit schizophrenia are partly mediated by executive impairments: Results of partial least squares path modeling",
        "Lowered antioxidant defenses and increased oxidative toxicity are hallmarks of deficit schizophrenia: A nomothetic network psychiatry approach",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: Results of supervised machine learning",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "High mobility group protein 1 and Dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: Associations with interleukin-6, symptom domains, and neurocognitive impairments",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products, and lower natural IgM to malondialdehyde",
        "Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity",
        "Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorder, and psychopathology in schizophrenia patients",
        "A new schizophrenia model: Immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Executive functioning in schizophrenia",
        "Psychosis-related matricide associated with a lesion of the ventromedial prefrontal cortex",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "The schedule for the deficit syndrome: An instrument for research in schizophrenia",
        "The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations",
        "Positive and negative syndromes in schizophrenia as a function of chronicity",
        "The Brief Psychiatric Rating Scale",
        "A rating scale for depression",
        "Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL)",
        "The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones",
        "Controlling the false discovery rate: A practical and powerful approach to multiple testing",
        "Program FACTOR at 10: Origins, development, and future directions",
        "A general approach for fitting pure exploratory bifactor models",
        "Structural equation modeling with the SmartPLS",
        "Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB",
        "Problem-solving and spatial working memory in patients with schizophrenia and with focal frontal and temporal lobe lesions",
        "Episodic memory in schizophrenia",
        "Organizational and visual memory deficits in schizophrenia and bipolar psychoses using the Rey-Osterrieth complex figure: Effects of duration of illness",
        "A preliminary validity study of the Cambridge neuropsychological test automated battery for the assessment of executive function in schizophrenia and bipolar disorder",
        "Frontal-striatal cognitive deficits in patients with chronic schizophrenia",
        "Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks",
        "Spatial working memory deficits in schizophrenia: Relationship with tardive dyskinesia and negative symptoms",
        "Working and strategic memory deficits in schizophrenia",
        "Spatial working memory and planning ability: Contrasts between schizophrenia and bipolar i disorder",
        "Episodic memory in schizophrenia: The influence of strategy use on behavior and brain activation",
        "Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-na\u00efve first-episode schizophrenia patients",
        "Spatial serial order processing in schizophrenia",
        "Neurocognitive impairments in deficit and non-deficit schizophrenia and their relationships with symptom dimensions and other clinical variables",
        "The role of negative symptoms and cognitive dysfunction in schizophrenia outcome",
        "Negative symptoms, and cognitive deficits: What is the nature of their relationship?",
        "Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses",
        "Clinical significance of neurological soft signs in schizophrenia: Factor analysis of the Neurological Evaluation Scale",
        "First episode psychosis patients show impaired cognitive function - A study of a South Asian population in the UK",
        "Prefrontal cortical dysfunction during visual perspective-taking in schizophrenia",
        "Improvements in negative symptoms and functional outcome after a new generation cognitive remediation program: A randomized controlled trial",
        "Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia",
        "The associations between visual attention and facial expression identification in patients with schizophrenia",
        "Translational functional neuroimaging in the explanation of depression",
        "Spearman's g found in 31 non-Western nations: Strong evidence that g is a universal phenomenon",
        "Measuring depression over time ... or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression",
        "How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry",
        "Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University"
    ]
}